The PSENEN Antibody, Biotin conjugated is a chemically modified immunoglobulin designed to detect Presenilin Enhancer Gamma-Secretase Subunit (PSENEN), a critical component of the γ-secretase complex. This conjugate leverages biotin's high-affinity binding to streptavidin, enabling amplified detection in assays like ELISA, Western blotting, and immunohistochemistry (IHC) . PSENEN, also known as PEN-2, regulates γ-secretase activity, which processes amyloid-β (Aβ) peptides linked to Alzheimer’s disease (AD) pathogenesis .
Target: PSENEN (UniProt: Q9NZ42).
Conjugate: Biotin, facilitating signal amplification via streptavidin-HRP or streptavidin-AP systems .
Applications: Research into AD, Notch signaling, and γ-secretase modulators .
PSENEN stabilizes the γ-secretase complex, consisting of presenilin (PSEN1/PSEN2), nicastrin, and APH-1 . Its conserved DYSLF motif in the C-terminus is essential for complex assembly and Aβ42/Aβ40 ratio modulation . Mutations in PSENEN are associated with familial acne inversa and early-onset AD .
Primary Antibody Binding: Biotinylated PSENEN antibody binds target protein.
Secondary Reagent: Streptavidin-HRP or streptavidin-AP conjugate binds biotin, enabling enzymatic detection (e.g., TMB substrate for colorimetric assays) .
Signal Amplification: Streptavidin’s high affinity (Kd ≈ 10⁻¹⁵ M) enhances detection of low-abundance PSENEN .
Versatility: Compatible with ELISA, Western blotting, and IHC protocols .
PSENEN regulates Aβ42/Aβ40 ratios, a therapeutic target in AD. A γ-secretase modulator binds PSENEN, reducing Aβ42 production .
Psenen−/− Fibroblasts: Show abolished Aβ40/42 generation and APP CTF accumulation, confirming PSENEN’s essential role in γ-secretase activity .
Cysteine Scanning: E49C mutant reacts with TS-XX-biotin, highlighting PSENEN’s extracellular topology .
SPDP cross-linker identifies proximity between PSENEN’s loop and PSEN1 CTF, supporting direct interactions in the active complex .